Canrenone
- Generic Name
- Canrenone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H28O3
- CAS Number
- 976-71-6
- Unique Ingredient Identifier
- 78O20X9J0U
- Background
Canrenone has been used in trials studying the diagnostic of Heart Failure.
- Associated Conditions
- Edema, Hypertension, Essential Hypertension, Primary Aldosteronism
- Associated Therapies
- -
Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2018-05-25
- Lead Sponsor
- National Institute of Cardiology, Warsaw, Poland
- Target Recruit Count
- 80
- Registration Number
- NCT03536806
Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)
- First Posted Date
- 2017-08-28
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- University of Pavia
- Target Recruit Count
- 502
- Registration Number
- NCT03263962
- Locations
- 🇮🇹
IRCCS Policlinico San Matteo, Pavia, Italy
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-11-27
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Heart Care Foundation
- Target Recruit Count
- 500
- Registration Number
- NCT00403910
- Locations
- 🇮🇹
Ospedale Sant'Andrea, Roma, Italy
🇮🇹Ospedale casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italy
🇮🇹Ospedale SS Annunziata, Sassari, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath